Cargando…

Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial

OBJECTIVES: To test the feasibility and acceptability of a randomised controlled trial (RCT) to evaluate a Smartphone-based self-management tool in Early Intervention in Psychosis (EIP) services. DESIGN: A two-arm unblinded feasibility RCT. SETTING: Six NHS EIP services in England. PARTICIPANTS: Adu...

Descripción completa

Detalles Bibliográficos
Autores principales: Steare, Thomas, O’Hanlon, Puffin, Eskinazi, Michelle, Osborn, David, Lloyd-Evans, Brynmor, Jones, Rebecca, Rostill, Helen, Amani, Sarah, Johnson, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451533/
https://www.ncbi.nlm.nih.gov/pubmed/32847902
http://dx.doi.org/10.1136/bmjopen-2019-034927
_version_ 1783574996912701440
author Steare, Thomas
O’Hanlon, Puffin
Eskinazi, Michelle
Osborn, David
Lloyd-Evans, Brynmor
Jones, Rebecca
Rostill, Helen
Amani, Sarah
Johnson, Sonia
author_facet Steare, Thomas
O’Hanlon, Puffin
Eskinazi, Michelle
Osborn, David
Lloyd-Evans, Brynmor
Jones, Rebecca
Rostill, Helen
Amani, Sarah
Johnson, Sonia
author_sort Steare, Thomas
collection PubMed
description OBJECTIVES: To test the feasibility and acceptability of a randomised controlled trial (RCT) to evaluate a Smartphone-based self-management tool in Early Intervention in Psychosis (EIP) services. DESIGN: A two-arm unblinded feasibility RCT. SETTING: Six NHS EIP services in England. PARTICIPANTS: Adults using EIP services who own an Android Smartphone. Participants were recruited until the recruitment target was met (n=40). INTERVENTIONS: Participants were randomised with a 1:1 allocation to one of two conditions: (1) treatment as usual from EIP services (TAU) or (2) TAU plus access to My Journey 3 on their own Smartphone. My Journey 3 features a range of self-management components including access to digital recovery and relapse prevention plans, medication tracking and symptom monitoring. My Journey 3 use was at the users’ discretion and was supported by EIP service clinicians. Participants had access for a median of 38.1 weeks. PRIMARY AND SECONDARY OUTCOME MEASURES: Feasibility outcomes included recruitment, follow-up rates and intervention engagement. Participant data on mental health outcomes were collected from clinical records and from research assessments at baseline, 4 months and 12 months. RESULTS: 83% and 75% of participants were retained in the trial at the 4-month and 12-month assessments. All treatment group participants had access to My Journey 3 during the trial, but technical difficulties caused delays in ensuring timely access to the intervention. The median number of My Journey 3 uses was 16.5 (IQR 8.5 to 23) and median total minutes spent using My Journey 3 was 26.8 (IQR 18.3 to 57.3). No serious adverse events were reported. CONCLUSIONS: Recruitment and retention were feasible. Within a trial context, My Journey 3 could be successfully delivered to adults using EIP services, but with relatively low usage rates. Further evaluation of the intervention in a larger trial may be warranted, but should include attention to implementation. TRIAL REGISTRATION: ISRCTN10004994.
format Online
Article
Text
id pubmed-7451533
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74515332020-09-02 Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial Steare, Thomas O’Hanlon, Puffin Eskinazi, Michelle Osborn, David Lloyd-Evans, Brynmor Jones, Rebecca Rostill, Helen Amani, Sarah Johnson, Sonia BMJ Open Mental Health OBJECTIVES: To test the feasibility and acceptability of a randomised controlled trial (RCT) to evaluate a Smartphone-based self-management tool in Early Intervention in Psychosis (EIP) services. DESIGN: A two-arm unblinded feasibility RCT. SETTING: Six NHS EIP services in England. PARTICIPANTS: Adults using EIP services who own an Android Smartphone. Participants were recruited until the recruitment target was met (n=40). INTERVENTIONS: Participants were randomised with a 1:1 allocation to one of two conditions: (1) treatment as usual from EIP services (TAU) or (2) TAU plus access to My Journey 3 on their own Smartphone. My Journey 3 features a range of self-management components including access to digital recovery and relapse prevention plans, medication tracking and symptom monitoring. My Journey 3 use was at the users’ discretion and was supported by EIP service clinicians. Participants had access for a median of 38.1 weeks. PRIMARY AND SECONDARY OUTCOME MEASURES: Feasibility outcomes included recruitment, follow-up rates and intervention engagement. Participant data on mental health outcomes were collected from clinical records and from research assessments at baseline, 4 months and 12 months. RESULTS: 83% and 75% of participants were retained in the trial at the 4-month and 12-month assessments. All treatment group participants had access to My Journey 3 during the trial, but technical difficulties caused delays in ensuring timely access to the intervention. The median number of My Journey 3 uses was 16.5 (IQR 8.5 to 23) and median total minutes spent using My Journey 3 was 26.8 (IQR 18.3 to 57.3). No serious adverse events were reported. CONCLUSIONS: Recruitment and retention were feasible. Within a trial context, My Journey 3 could be successfully delivered to adults using EIP services, but with relatively low usage rates. Further evaluation of the intervention in a larger trial may be warranted, but should include attention to implementation. TRIAL REGISTRATION: ISRCTN10004994. BMJ Publishing Group 2020-08-26 /pmc/articles/PMC7451533/ /pubmed/32847902 http://dx.doi.org/10.1136/bmjopen-2019-034927 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Mental Health
Steare, Thomas
O’Hanlon, Puffin
Eskinazi, Michelle
Osborn, David
Lloyd-Evans, Brynmor
Jones, Rebecca
Rostill, Helen
Amani, Sarah
Johnson, Sonia
Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial
title Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial
title_full Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial
title_fullStr Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial
title_full_unstemmed Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial
title_short Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial
title_sort smartphone-delivered self-management for first-episode psychosis: the aries feasibility randomised controlled trial
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451533/
https://www.ncbi.nlm.nih.gov/pubmed/32847902
http://dx.doi.org/10.1136/bmjopen-2019-034927
work_keys_str_mv AT stearethomas smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT ohanlonpuffin smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT eskinazimichelle smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT osborndavid smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT lloydevansbrynmor smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT jonesrebecca smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT rostillhelen smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT amanisarah smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial
AT johnsonsonia smartphonedeliveredselfmanagementforfirstepisodepsychosistheariesfeasibilityrandomisedcontrolledtrial